Terms: = Brain cancer AND WRN, RECQL2, 7486, ENSG00000165392, Q14191, RECQ3 AND Prognosis
5 results:
1. Construction of a SUMOylation regulator-based prognostic model in low-grade glioma.
Li X; Meng Y
J Cell Mol Med; 2021 Jun; 25(12):5434-5442. PubMed ID: 33951297
[TBL] [Abstract] [Full Text] [Related]
2. Multimodal brain tumor image segmentation using wrn-PPNet.
Wang Y; Li C; Zhu T; Zhang J
Comput Med Imaging Graph; 2019 Jul; 75():56-65. PubMed ID: 31154088
[TBL] [Abstract] [Full Text] [Related]
3. Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients.
Song Q; Shang J; Zhang C; Zhang L; Wu X
J Cancer Res Clin Oncol; 2019 Mar; 145(3):737-746. PubMed ID: 30603904
[TBL] [Abstract] [Full Text] [Related]
4. The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer.
Matsushita Y; Yokoyama Y; Yoshida H; Osawa Y; Mizunuma M; Shigeto T; Futagami M; Imaizumi T; Mizunuma H
J Ovarian Res; 2014 Nov; 7():107. PubMed ID: 25424877
[TBL] [Abstract] [Full Text] [Related]
5. Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility.
Tatenhorst L; Senner V; Püttmann S; Paulus W
J Neuropathol Exp Neurol; 2004 Mar; 63(3):210-22. PubMed ID: 15055445
[TBL] [Abstract] [Full Text] [Related]
